G. Jerums

1.8k total citations
25 papers, 1.5k citations indexed

About

G. Jerums is a scholar working on Nephrology, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, G. Jerums has authored 25 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Nephrology, 11 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in G. Jerums's work include Chronic Kidney Disease and Diabetes (19 papers), Diabetes Treatment and Management (7 papers) and Blood Pressure and Hypertension Studies (6 papers). G. Jerums is often cited by papers focused on Chronic Kidney Disease and Diabetes (19 papers), Diabetes Treatment and Management (7 papers) and Blood Pressure and Hypertension Studies (6 papers). G. Jerums collaborates with scholars based in Australia, United Kingdom and United States. G. Jerums's co-authors include Tanya M. Osicka, Terri J. Allen, Josephine M. Forbes, Vicki Thallas, David J. Nikolic‐Paterson, Leon A. Bach, Robert C. Atkins, Richard E. Gilbert, Mark E. Cooper and M. E. Cooper and has published in prestigious journals such as Journal of Clinical Investigation, Diabetes and Kidney International.

In The Last Decade

G. Jerums

25 papers receiving 1.4k citations

Peers

G. Jerums

NEPHR

EDM

CCM

Christiane Rüster Germany

Michele Dalla Vestra Italy

Keith Drummond Canada

Hitomi Usui Japan

Bieke F. Schrijvers Denmark

Mitsunori Yagame Japan

G Stein Germany

Eberhard Ritz Germany

Alois Saller Italy

C. Wanner Germany

Christiane Rüster Germany

G. Jerums

495 ×0.6

NEPHR

280 ×0.7

320 ×0.8

EDM

313 ×1.0

244 ×0.8

CCM

Citations per year, relative to G. Jerums G. Jerums (= 1×) peers Christiane Rüster

Countries citing papers authored by G. Jerums

Since Specialization

Citations

This map shows the geographic impact of G. Jerums's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Jerums with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Jerums more than expected).

Fields of papers citing papers by G. Jerums

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Jerums. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Jerums. The network helps show where G. Jerums may publish in the future.

Co-authorship network of co-authors of G. Jerums

This figure shows the co-authorship network connecting the top 25 collaborators of G. Jerums. A scholar is included among the top collaborators of G. Jerums based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Jerums. G. Jerums is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jerums, G., Sianna Panagiotopoulos, Elif I. Ekinci, & R. J. MacIsaac. (2015). Cardiovascular outcomes with antihypertensive therapy in type 2 diabetes: an analysis of intervention trials. Journal of Human Hypertension. 29(8). 473–477. 7 indexed citations

Chadban, Steven J., Martin Howell, Stephen M. Twigg, et al.. (2010). Cost‐effectiveness and socioeconomic implications of prevention and management of chronic kidney disease in type 2 diabetes. Nephrology. 15(s1). S195–203. 10 indexed citations

Yip, Gabriel Wai‐Kwok, et al.. (2010). Carbimazole‐induced agranulocytosis: does antineutrophil cytoplasmic antibody have a role?. Internal Medicine Journal. 40(4). 300–303. 1 indexed citations

Chadban, Steven J., Martin Howell, Stephen M. Twigg, et al.. (2010). Prevention and management of chronic kidney disease in type 2 diabetes. Nephrology. 15(s1). S162–94. 17 indexed citations

MacIsaac, R. J., G. Jerums, Andrew Weekes, & Merlin C. Thomas. (2008). Patterns of glycaemic control in Australian primary care (NEFRON 8). Internal Medicine Journal. 39(8). 512–518. 23 indexed citations

MacIsaac, Richard J., Con Tsalamandris, Merlin C. Thomas, et al.. (2006). Estimating glomerular filtration rate in diabetes: a comparison of cystatin-C- and creatinine-based methods. Diabetologia. 49(7). 1686–1689. 118 indexed citations

Jerums, G., Terri J. Allen, D. Campbell, et al.. (2004). Long‐term renoprotection by perindopril or nifedipine in non‐hypertensive patients with Type 2 diabetes and microalbuminuria. Diabetic Medicine. 21(11). 1192–1199. 22 indexed citations

Bach, Leon A., Josephine M. Forbes, David J. Nikolic‐Paterson, et al.. (2001). Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE). Journal of Clinical Investigation. 108(12). 1853–1863. 397 indexed citations

Osicka, Tanya M., Yanni Yu, Sianna Panagiotopoulos, et al.. (2000). Prevention of albuminuria by aminoguanidine or ramipril in streptozotocin-induced diabetic rats is associated with the normalization of glomerular protein kinase C.. Diabetes. 49(1). 87–93. 101 indexed citations

10.

Osicka, Tanya M., Christine Houlihan, J. Gordon Chan, G. Jerums, & Wayne D. Comper. (2000). Albuminuria in patients with type 1 diabetes is directly linked to changes in the lysosome-mediated degradation of albumin during renal passage.. Diabetes. 49(9). 1579–1584. 120 indexed citations

11.

Gilbert, Richard E., Jennifer L. Wilkinson‐Berka, David W. Johnson, et al.. (1998). Renal expression of transforming growth factor-β inducible gene-h3 (βig-h3) in normal and diabetic rats. Kidney International. 54(4). 1052–1062. 78 indexed citations

12.

Soulis, Tina, Mark E. Cooper, Dimitria Vranes, Richard Bucala, & G. Jerums. (1996). Effects of aminoguanidine in preventing experimental diabetic nephropathy are related to the duration of treatment. Kidney International. 50(2). 627–634. 127 indexed citations

13.

Allen, Terri J., et al.. (1996). Serum total renin is increased before microalbuminuria in diabetes. Kidney International. 50(3). 902–907. 41 indexed citations

14.

Gilbert, Richard E., Alison J. Cox, Marie Dziadek, Mark E. Cooper, & G. Jerums. (1995). Extracellular matrix and its interactions in the diabetic kidney: A molecular biological approach. Journal of Diabetes and its Complications. 9(4). 252–254. 16 indexed citations

15.

Jerums, G., Terri J. Allen, Richard E. Gilbert, et al.. (1995). Natural history of early diabetic nephropathy: What are the effects of therapeutic intervention?. Journal of Diabetes and its Complications. 9(4). 308–314. 3 indexed citations

16.

Jerums, G., Terri J. Allen, Con Tsalamandris, et al.. (1993). Relationship of progressively increasing albuminuria to apoprotein(a) and blood pressure in Type 2 (non-insulin-dependent) and Type 1 (insulin-dependent) diabetic patients. Diabetologia. 36(10). 1037–1044. 37 indexed citations

17.

Akdeniz, Aysel, et al.. (1992). Semi‐quantitative determination of microalbuminuri by urinary dipstick. Australian and New Zealand Journal of Medicine. 22(4). 334–337. 18 indexed citations

18.

Cooper, M. E., et al.. (1992). Antihypertensive therapy in a model combining spontaneous hypertension with diabetes. Kidney International. 41(4). 898–903. 45 indexed citations

19.

Jerums, G., Terri J. Allen, Con Tsalamandris, & Mark E. Cooper. (1992). Angiotensin converting enzyme inhibition and calcium channel blockade in incipient diabetic nephropathy. Kidney International. 41(4). 904–911. 33 indexed citations

20.

Cooper, Mark E., et al.. (1989). Intermittent diabetic microalbuminuria: Association with blood pressure, glycemic control, and protein intake. Journal of Diabetic Complications. 3(2). 92–98. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact